Trusted Resources: Evidence & Education
Scientific literature and patient education texts
Thyroid Carcinoma in Graves’ Disease: A Meta-Analysis
source: International Journal of Surgery
year: 2016
authors: Staniforth JU, Erdirimanne S, Eslick GD
summary/abstract:Background:
The incidence of thyroid carcinoma is increasing worldwide. Graves’ disease is the most common hyperthyroid disease. Studies have suggested an increased risk of thyroid malignancy in Graves’ disease: there has not yet been a meta-analysis to allow quantitative comparison. The purpose of this study was to determine the risk of thyroid carcinoma in Graves’ disease, and to gather information on the histological subtypes of carcinoma and the co-existence of thyroid nodules.
Methods:
Several databases and article reference lists were searched. Inclusion criteria included appropriate diagnostic criteria for thyroid conditions and a diagnoses of carcinoma based on histology.
Results:
33 studies were selected, all reporting on surgically-resected specimens. The event rate of thyroid carcinoma in Graves’ disease was 0.07 (95% CI 0.04 to 0.12). There was no data to allow comparison with patients without hyperthyroid diseases. There was no increase in the odds of developing carcinoma in Graves’ disease compared to toxic multinodular goitre and toxic uninodular goitre. 88% of thyroid carcinomas in Graves’ disease were papillary, with solitary papillary micro-carcinoma (diameter 10 mm or less) comprising 23% of all detected thyroid carcinomas. Patients with Graves’ disease and co-existing thyroid nodules were almost 5 times more likely to be diagnosed with thyroid carcinoma than those without nodules.
Conclusion:
Thyroid malignancy in Graves’ disease requiring surgical treatment should be considered as likely as in other hyperthyroid diseases needing surgical treatment. Clinicians should consider screening selected patients with Graves’ disease for nodules whilst being aware of potentially over-diagnosing papillary micro-carcinoma.
DOI: 10.1016/j.ijsu.2015.11.027
read more full text
Related Content
-
Hackensack Meridian Health, Jersey Shore University Medical Center – Center for Thyroid, Parathyroid and Adren...The endocrine services at Jersey Shore U...
-
Basic Understanding About Graves’ DiseaseWhat Is Graves’ Disease? Graves’ di...
-
Clinical and Socioeconomic Factors Influence Treatment Decisions in Graves’ DiseaseBackground: Definitive treatment of Gra...
-
ASOPRS 2022 Fall Scientific SymposiumThe American Society of Ophthalmic Pla...
-
Radioiodine Ablation of Postsurgical Thyroid Remnants After Treatment With Recombinant Human TSH (rhTSH) in Patients...Context: Recent evidence suggests thyro...
-
Rebecca S. Sippel, MD, FACSRebecca S. Sippel is a Professor of Surg...
-
Rose Thyroid & Parathyroid CenterAs the largest thyroid and parathyroid p...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.